U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07704216) titled 'Peritumoral MRE Stiffness for Predicting Resection Margin Status and Recurrence in Liver Cancer' on July 10.
Brief Summary: Microscopic residual tumor at the resection margin is a critical risk factor for recurrence in patients undergoing hepatectomy for liver cancer, yet current detection relies solely on postoperative pathological examination of the resected specimen, which reflects only the removed tissue rather than the actual remnant liver in the patient. How to non-invasively detect residual tumor at the resection margin of the remnant liver after surgery remains an important unresolved problem in the surgical management of li...